NASDAQ Endocrinology Market News

Chiasma Reports Third Quarter 2017 Results

WALTHAM, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical ...

Chiasma Reports Third Quarter 2017 Results

WALTHAM, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical ...

Ascendis Pharma A/S Announces Third Quarter 2017 Financial Results Conference Call on November 16

COPENHAGEN, Denmark, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

Ascendis Pharma A/S Announces Third Quarter 2017 Financial Results Conference Call on November 16

COPENHAGEN, Denmark, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

Caroline Apovian Named President of The Obesity Society

National Harbor, MD, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Caroline Apovian, MD, FACP, FACN, ...

Caroline Apovian Named President of The Obesity Society

National Harbor, MD, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Caroline Apovian, MD, FACP, FACN, ...

Ascendis Pharma A/S Announces Participation in Two Upcoming Investor Conferences

COPENHAGEN, Denmark, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

Ascendis Pharma A/S Announces Participation in Two Upcoming Investor Conferences

COPENHAGEN, Denmark, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

[sam_pro id=0_12 codes="true"]